Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Reviews |19 November 2019

Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence: A Systematic Review and Meta-analysis of Cohort Studies Free

Mi Ah Han, MD, PhD; Dena Zeraatkar, MSc; Gordon H. Guyatt, MD; Robin W.M. Vernooij, PhD; Regina El Dib, PhD; Ying Zhang, PhD; Abdullah Algarni, MBBS; Gareth Leung, BHSc; Dawid Storman, MD; Claudia Valli, MSc; Montserrat Rabassa, PhD; Nadia Rehman, BDS; Michael K. Parvizian, BHSc; Max Zworth, BA⪼ Jessica J. Bartoszko, HBSc; Luciane Cruz Lopes, PhD; Daegan Sit, MD; Malgorzata M. Bala, MD, PhD; Pablo Alonso-Coello, MD, PhD; Bradley C. Johnston, PhD

Mi Ah Han, MD, PhD
Chosun University, Gwangju, Republic of Korea (M.A.H.)

Dena Zeraatkar, MSc
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Gordon H. Guyatt, MD
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Robin W.M. Vernooij, PhD
Dalhousie University, Halifax, Nova Scotia, Canada, and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands (R.W.V.)

Regina El Dib, PhD
Science and Technology Institute, Universidade Estadual Paulista, São José dos Campos, São Paulo, Brazil, and Dalhousie University, Halifax, Nova Scotia, Canada (R.E.)

Ying Zhang, PhD
Beijing University of Chinese Medicine, Beijing, China (Y.Z.)

Abdullah Algarni, MBBS
Aseer Central Hospital, Abha, Saudi Arabia (A.A.)

Gareth Leung, BHSc
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Dawid Storman, MD
Jagiellonian University Medical College, Kraków, Poland (D.S.)

Claudia Valli, MSc
Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute Sant Pau, and CIBER de Epidemiología y Salud Pública, Barcelona, Spain (C.V., M.R.)

Montserrat Rabassa, PhD
Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute Sant Pau, and CIBER de Epidemiología y Salud Pública, Barcelona, Spain (C.V., M.R.)

Nadia Rehman, BDS
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Michael K. Parvizian, BHSc
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Max Zworth, BA&Sc
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Jessica J. Bartoszko, HBSc
McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)

Luciane Cruz Lopes, PhD
University of Sorocaba, Sorocaba, Sao Paulo, Brazil (L.C.L.)

Daegan Sit, MD
University of British Columbia, Vancouver, British Columbia, Canada (D.S.)

Malgorzata M. Bala, MD, PhD
Jagiellonian University Medical College, Krakow, Poland (M.M.B.)

Pablo Alonso-Coello, MD, PhD
McMaster University, Hamilton, Ontario, Canada, and Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute Sant Pau, and CIBER de Epidemiología y Salud Pública, Barcelona, Spain (P.A.)

Bradley C. Johnston, PhD
Dalhousie University, Halifax, Nova Scotia, and McMaster University, Hamilton, Ontario, Canada (B.C.J.)

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 1 October 2019.
  • Chosun University, Gwangju, Republic of Korea (M.A.H.)
    McMaster University, Hamilton, Ontario, Canada (D.Z., G.H.G., G.L., N.R., M.K.P., M.Z., J.J.B.)
    Dalhousie University, Halifax, Nova Scotia, Canada, and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands (R.W.V.)
    Science and Technology Institute, Universidade Estadual Paulista, São José dos Campos, São Paulo, Brazil, and Dalhousie University, Halifax, Nova Scotia, Canada (R.E.)
    Beijing University of Chinese Medicine, Beijing, China (Y.Z.)
    Aseer Central Hospital, Abha, Saudi Arabia (A.A.)
    Jagiellonian University Medical College, Kraków, Poland (D.S.)
    Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute Sant Pau, and CIBER de Epidemiología y Salud Pública, Barcelona, Spain (C.V., M.R.)
    University of Sorocaba, Sorocaba, Sao Paulo, Brazil (L.C.L.)
    University of British Columbia, Vancouver, British Columbia, Canada (D.S.)
    Jagiellonian University Medical College, Krakow, Poland (M.M.B.)
    McMaster University, Hamilton, Ontario, Canada, and Iberoamerican Cochrane Centre Barcelona, Biomedical Research Institute Sant Pau, and CIBER de Epidemiología y Salud Pública, Barcelona, Spain (P.A.)
    Dalhousie University, Halifax, Nova Scotia, and McMaster University, Hamilton, Ontario, Canada (B.C.J.)

    Note: Drs. Han, Guyatt, and Johnston and Ms. Zeraatkar act as the guarantors of this article.

    Acknowledgment: The authors thank Thomasin Adams-Webber (Hospital for Sick Children) for her help designing the search strategy.

    Disclosures: Dr. El Dib received a São Paulo Research Foundation (FAPESP) (2018/11205-6) scholarship and funding from the National Council for Scientific and Technological Development (CNPq) (CNPq 310953/2015-4) and the Faculty of Medicine, Dalhousie University. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-0699.

    Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.

    >Reproducible Research Statement: Study protocol: Registered in PROSPERO (CRD42017074074). Statistical code: See Methods and Appendix. Code is available on request. Data set: See the tables and Appendix. Data are available on request from Dr. Han (e-mail, mahan@chosun.ac.kr).

    Corresponding Author: Gordon H. Guyatt, MD, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 3Z5, Canada; e-mail, guyatt@mcmaster.ca.

    Current Author Addresses: Dr. Han: Department of Preventive Medicine, College of Medicine, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea.

    Ms. Zeraatkar, Drs. Guyatt and Rehman, Mr. Leung, Mr. Parvizian, Mr. Zworth, and Ms. Bartoszko: McMaster University Health Sciences Center, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.

    Dr. Vernooij: Department of Research, Netherlands Comprehensive Cancer Organisationn, Godebaldkwartier 419, Utrecht 3511DT, the Netherlands.

    Dr. El Dib: Institute of Science and Technology, Universidade Estadual Paulista, Avenida Engenheiro Francisco José Longo, 777, Jardim São Dimas, São José dos Campos, Sao Paolo 12245-000, Brazil.

    Dr. Zhang: Center for Evidence-based Chinese Medicine, Beijing University, 11 Beisanhuan Dong Lu, Chaoyang District, Beijing 100029, China.

    Dr. Algarni: Department of Internal Medicine, Aseer Central Hospital, 4076 Al Muruj, Unit 3, Al Rabwah, Abha 62523, Saudi Arabia.

    Drs. Storman and Bala: Department of Hygiene and Dietetics, Jagiellonian University Medical College, 7 Kopernika Street, Kraków 31-034, Poland.

    Ms. Valli and Drs. Rabassa and Alonso-Coello: Iberoamerican Cochrane Centre, Instituto de Investigación Biomédica de Sant Pau (IIB Sant Pau-CIBERESP), Carrer de Sant Antoni Maria Claret, 167, Barcelona 08025, Spain.

    Dr. Lopes: University of Sorocaba (UNISO), Rodovia Raposo Tavares, Km 92,5, Sorocaba, Sao Paulo 180230-000, Brazil.

    Dr. Sit: University of British Columbia, 107-1165 West 13th Avenue, Vancouver, British Columbia V6H 1N4, Canada.

    Dr. Johnston: Department of Community Health and Epidemiology, Centre for Clinical Research, Dalhousie University, 5790 University Avenue, Room 404, Halifax, Nova Scotia B3J 0E4, Canada.

    Author Contributions: Conception and design: M.A. Han, D. Zeraatkar, G.H. Guyatt, M.M. Bala, P. Alonso-Coello, B.C. Johnston.

    Analysis and interpretation of the data: M.A. Han, D. Zeraatkar, R. El Dib, M. Rabassa, N. Rehman, D. Sit, M.M. Bala, P. Alonso-Coello, B.C. Johnston.

    Drafting of the article: M.A. Han, R. El Dib, D. Sit, B.C. Johnston.

    Critical revision of the article for important intellectual content: M.A. Han, D. Zeraatkar, G.H. Guyatt, R.W.M. Vernooij, D. Sit, M.M. Bala, P. Alonso-Coello, B.C. Johnston.

    Final approval of the article: M.A. Han, D. Zeraatkar, G.H. Guyatt, R.W.M. Vernooij, R. El Dib, Y. Zhang, A. Algarni, G. Leung, D. Storman, C. Valli, M. Rabassa, N. Rehman, M.K. Parvizian, M. Zworth, J.J. Bartoszko, L.C. Lopes, D. Sit, M.M. Bala, P. Alonso-Coello, B.C. Johnston.

    Statistical expertise: M.A. Han, D. Zeraatkar.

    Administrative, technical, or logistic support: M.A. Han, D. Zeraatkar.

    Collection and assembly of data: M.A. Han, D. Zeraatkar, R.W.M. Vernooij, Y. Zhang, A. Algarni, G. Leung, D. Storman, C. Valli, M. Rabassa, M.K. Parvizian, M. Zworth, J.J. Bartoszko, L.C. Lopes, D. Sit, B.C. Johnston.

×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Abstract
    • Methods
    • Results
    • Discussion
    • Appendix: Technical Appendix
      1. References
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

Abstract

Background:

Cancer incidence has continuously increased over the past few centuries and represents a major health burden worldwide.

Purpose:

To evaluate the possible causal relationship between intake of red and processed meat and cancer mortality and incidence.

Data Sources:

Embase, Cochrane Central Register of Controlled Trials, Web of Science, CINAHL, and ProQuest from inception until July 2018 and MEDLINE from inception until April 2019 without language restrictions.

Study Selection:

Cohort studies that included more than 1000 adults and reported the association between consumption of unprocessed red and processed meat and cancer mortality and incidence.

Data Extraction:

Teams of 2 reviewers independently extracted data and assessed risk of bias; 1 reviewer evaluated the certainty of evidence, which was confirmed or revised by the senior reviewer.

Data Synthesis:

Of 118 articles (56 cohorts) with more than 6 million participants, 73 articles were eligible for the dose–response meta-analyses, 30 addressed cancer mortality, and 80 reported cancer incidence. Low-certainty evidence suggested that an intake reduction of 3 servings of unprocessed meat per week was associated with a very small reduction in overall cancer mortality over a lifetime. Evidence of low to very low certainty suggested that each intake reduction of 3 servings of processed meat per week was associated with very small decreases in overall cancer mortality over a lifetime; prostate cancer mortality; and incidence of esophageal, colorectal, and breast cancer.

Limitation:

Limited causal inferences due to residual confounding in observational studies, risk of bias due to limitations in diet assessment and adjustment for confounders, recall bias in dietary assessment, and insufficient data for planned subgroup analyses.

Conclusion:

The possible absolute effects of red and processed meat consumption on cancer mortality and incidence are very small, and the certainty of evidence is low to very low.

Primary Funding Source:

None. (PROSPERO: CRD42017074074)

Cancer is the leading cause of morbidity and mortality worldwide (1). Authorities have postulated that diet—in particular, consumption of red meat and processed meat—may be a determinant of cancer risk (2). Many primary studies have reported an association between red and processed meat consumption and cancer mortality and incidence (3–12). In response, the International Agency for Research on Cancer classified consumption of processed meat as carcinogenic to humans on the basis of evidence about colorectal cancer (group 1) and classified that of red meat as probably carcinogenic on the basis of evidence about colorectal, pancreatic, and prostate cancer (group 2A) (13). The World Cancer Research Fund and American Institute for Cancer Research advise limiting red meat consumption to no more than about 3 portions per week (<500 g weekly) and consuming very little, if any, processed meat (14).
Many systematic reviews have supported the association between red or processed meat and cancer mortality or incidence. However, most have focused on specific types of cancer and have not provided a comprehensive overview (15–18). Some have limited their analyses to comparing extreme exposure categories rather than conducting the optimal dose–response analysis that uses the entirety of data from cohort studies (19–22). Few have formally rated the certainty of evidence supporting the inference that red and processed meat consumption is causally related to cancer.
We did this systematic review addressing the possible effect of red and processed meat on cancer as part of NutriRECS (Nutritional Recommendations and accessible Evidence summaries Composed of Systematic reviews), the goal of which is to develop trustworthy guideline recommendations on nutrition (23). We did 5 parallel systematic reviews (24–27) and developed the guideline for red meat and health outcomes (28). This current review focuses on observational studies addressing cancer outcomes; we summarized results from cohort studies by conducting dose–response meta-analyses and used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology (29) to rate the certainty of evidence supporting the absolute effects of meat consumption on cancer incidence and mortality.

Methods

The protocol for this review was registered in PROSPERO (CRD42017074074) in August 2017.

Data Sources and Searches

We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science, CINAHL, and ProQuest from inception to July 2018 and updated our MEDLINE search to April 2019. An experienced librarian developed a search strategy (Supplement Table 1,). We checked the reference lists of published systematic reviews to identify additional relevant studies.

Study Selection

We included cohort studies with more than 1000 participants aged 18 years or older that reported effect estimates and corresponding 95% CIs. Studies had to report associations between red or processed meat consumption and mortality from or incidence of any of the following: cancer overall, gastrointestinal cancer (oral, esophageal, gastric, small intestinal, colorectal, hepatic, pancreatic, or gallbladder), female cancer types (ovarian, endometrial, or breast), or prostate cancer. We applied no restrictions on language or publication status.
We excluded studies if they reported only on a specific type of red meat (such as beef or lamb) or a specific type of processed meat (such as hot dogs). Studies were excluded if more than 20% of the sample was pregnant or had a major chronic illness at baseline, including cancer, and participants without these conditions were not reported separately. We also excluded studies that asked participants to recall their diet at a previous point in their life (for example, if adults recalled their diet during adolescence and childhood or middle-aged adults recalled their diet during young adulthood).
After calibration exercises, teams of 2 reviewers independently screened titles and abstracts. Articles that either reviewer judged as potentially eligible then had full-text screening. Raters resolved disagreements by discussion or, if necessary, with a third reviewer. If authors published multiple reports from the same cohort, we selected the study with the longest follow-up.

Data Extraction and Quality Assessment

We did calibration exercises, and teams of 2 independent reviewers extracted data and addressed risk of bias, resolving discrepancies by discussion or consultation with a third reviewer. We used a predefined extraction form in Excel (Microsoft) for each study and included cohort name, country where the study was done, number of eligible participants at baseline, age and sex of participants, type of red and processed meat, amount of intake, type of cancer, years of follow-up, number of participants analyzed within exposure category, number of person-years, number of cases, and effect estimates and 95% CIs. If a study reported more than 1 adjusted effect estimate, we selected the most adjusted value.
We classified red and processed meat into the following 3 types: unprocessed red meat; processed meat; and mixed unprocessed red meat, processed meat, and unspecified red meat. Meat from mammals was classified as red meat. Processed meat was defined as meat that has been preserved by smoking, curing, salting, or adding preservatives (for example, hot dogs, charcuterie, sausage, ham, and cold-cut deli meats). Red meat was classified as unprocessed when authors explicitly described it as such and stated that processed red meat was not included. Without such a statement, we classified the exposure as an unspecified type of red meat.
To address risk of bias, we used a modified version of the Clinical Advances through Research and Information Technology risk of bias tool (30). After resolving discrepancies, we classified items rated “definitely low” and “probably low” as having low risk of bias and those rated “probably high” and “definitely high” as having high risk of bias. Through consultation with research methodologists and nutrition researchers, we developed criteria to evaluate each item (Supplement Table 2). We regarded all items as equally important and rated a study as having high risk of bias if 2 or more items had high risk of bias. This threshold, although somewhat arbitrary, represents a compromise between excessive stringency and problematic leniency.

Data Synthesis and Analysis

Using dose–response meta-analysis, as proposed by Greenland and Longnecker (31) and Orsini and colleagues (32), we calculated pooled relative risks (RRs) and 95% CIs for the effect of an intake reduction of 3 servings of red or processed meat per week on cancer mortality or incidence. We chose 3 servings per week because, on the basis of the average intake of red and processed meat (approximately 2 to 4 servings of each type per week [33]), this is likely to be a maximal realistic reduction in mean for most persons. For a study to be included in dose–response meta-analyses, it needed to state the quantity of intake, number of cases, number of person-years or participants, effect estimates, and 95% CIs across exposure categories or sufficient information to calculate these details. When quantity of exposure was reported as a range, the midpoint of the upper and lower boundaries was assigned as the exposure value. When the category was open-ended, we assumed that the interval between boundaries was the same as that of the adjacent category. When authors did not report the number of person-years or participants included in a specific category but instead reported exposure by quantile, such as quartile or quintile, we assumed that numbers of person-years or participants were approximately equal in each category. We preferred to use number of person-years but used number of participants in the absence of person-years. When studies used different units (such as servings and times) to report the exposure, we converted them into grams per day using standard conversions from the Food Standards Agency and other documents (34–41). One serving was 120 g for unprocessed red meat, 50 g for processed meat, and 100 g for mixed unprocessed red and processed meat. When studies used grams per 1000 kcal as the unit, we also converted into grams per day according to the average energy intake of the population included in the study. Studies reporting only risk estimates per unit increase in exposure (such as per 50 g/d) were also included in the dose–response meta-analysis; we calculated a regression coefficient based on the relative effect reported and meta-analyzed these regression coefficients with effects obtained from other studies (31). We examined the nonlinear association between red meat intake and cancer risk for analyses that included 5 or more studies by using restricted cubic splines with knots at 10%, 50%, and 90% and a Wald-type test, which tests the null hypothesis that the regression coefficient of the second spline is equal to 0. We presented an RR from the nonlinear model when we observed a statistically significant nonlinear association. The  Appendix gives details of the dose–response meta-analysis.
We also did meta-analyses comparing the lowest versus the highest category of intake using the Hartung–Knapp random-effects model (42) and presented DerSimonian–Laird random effects as a sensitivity analysis (43).
For both dose–response and lowest-versus-highest meta-analyses, we used meta-regression analysis to investigate whether the summary estimates are robust to risk of bias. Heterogeneity among studies was examined by inspecting forest plots for overlapping CIs, I2 statistics, and Q statistics. Publication bias was assessed using the Egger test in meta-analyses with more than 10 studies. All statistical analyses were done using R software, version 3.5.1 (R Foundation).
Because we have greater confidence in results from dose–response meta-analysis, we based our inferences primarily on these results and preferentially present them in the included summary-of-findings tables. For outcomes with no studies eligible for dose–response meta-analysis, we present results from lowest-versus-highest meta-analyses.

Certainty of Evidence

We used GRADE to assess the certainty of evidence by rating each cancer outcome as high, moderate, low, or very low. One reviewer evaluated certainty of evidence, which was confirmed or revised by the senior reviewer. Evidence from observational studies begins at low certainty and may be increased to moderate or high certainty when a large effect is observed, when all plausible biases would work in a direction opposite to the observed effect, or when a dose–response gradient is present. Observational studies may be downgraded to very low certainty on the basis of risk of bias, inconsistency, indirectness, imprecision, or publication bias (44). We considered increasing certainty for dose response but ultimately decided not to do so because quantity of red meat consumption may track with other dietary and behavioral factors. This decision was influenced by the results of a parallel systematic review showing that the association between dietary patterns and cancer is similar in magnitude to that between red meat and cancer (26). We calculated the risk difference by multiplying the pooled RR reduction from the meta-analysis by the population risk for cancer incidence and mortality. Global cancer statistics (GLOBOCAN) produced by the International Agency for Research on Cancer (45) provided the cumulative risk for developing or dying of cancer before age 75 years using age-specific incidence and mortality rates based on 184 national data registries; we used these rates to estimate the population risk for cancer (lifetime risk). When the RR calculated from studies at low risk of bias differed from that from studies at high risk of bias, determined on the basis of a statistically significant test of interaction, we used the former rather than that from all eligible studies (46).

Role of the Funding Source

This study received no external funding or other support.

Results

Study Selection

Of the 22 882 articles identified through database searches and other sources, 9724 were duplicates. We assessed full texts of 1505 studies for eligibility, of which 118 articles reporting on 56 cohorts with 6.1 million participants were eligible. Evidence for the dose–response meta-analyses came from 73 articles (40 cohorts), of which 18 (17 cohorts) addressed consumption of unprocessed red meat, 56 (31 cohorts) processed red meat, and 60 (30 cohorts) mixed unprocessed red and processed meat (Appendix Figure 1).
Appendix Figure 1.

Evidence search and selection.

Study Characteristics

We found numerous reports addressing cancer mortality: 19 on cancer overall, 7 on gastric cancer, 8 on colorectal cancer, 3 on pancreatic cancer, 1 on ovarian cancer, 6 on breast cancer, and 11 on prostate cancer. We also found articles that reported cancer incidence: 5 on cancer overall, 2 on oral cancer, 3 on esophageal cancer, 8 on gastric cancer, 1 on small intestinal cancer, 35 on colorectal cancer, 2 on hepatic cancer, 15 on pancreatic cancer, 2 on ovarian cancer, 5 on endometrial cancer, 18 on breast cancer, and 12 on prostate cancer. Sample size in cohort studies varied from 1904 to 1 102 308 participants, followed from 3 to 34 years, and age at baseline from 36.4 to 77 years (Supplement Table 3). A total of 99 articles reported funding from public or private nonprofit organizations. Of the eligible reports addressing cancer mortality, the following proportions had high risk of bias due to lack of repeated measurement of diet and lack of adjustment for important confounding variables: 9 of 19 on cancer overall, 6 of 7 on gastric cancer, 8 of 8 on colorectal cancer, 2 of 3 on pancreatic cancer, 1 of 1 on ovarian cancer, 6 of 6 on breast cancer, and 7 of 11 on prostate cancer. Of the eligible reports addressing cancer incidence, the following proportions had high risk of bias for the same reasons: 3 of 5 on cancer overall, 1 of 2 on oral cancer, 3 of 3 on esophageal cancer, 8 of 8 on gastric cancer, 0 of 1 on small intestinal cancer, 16 of 35 on colorectal cancer, 1 of 2 on hepatic cancer, 11 of 15 on pancreatic cancer, 1 of 2 on ovarian cancer, 5 of 5 on endometrial cancer, 5 of 18 on breast cancer, and 5 of 12 on prostate cancer (Supplement Table 4).

Dose–Response Meta-analysis of a Reduction in Unprocessed Red Meat Intake of 3 Servings per Week and Cancer Mortality and Incidence

An intake reduction in unprocessed red meat of 3 servings per week was associated with a very small decrease in overall cancer mortality. This reduction was not statistically significantly associated with overall incidence of cancer or incidence of esophageal, gastric, colorectal, pancreatic, breast, or prostate cancer. Data on prostate cancer mortality were available only for lowest-versus-highest meta-analysis, and no statistically significant association was found (Table 1). We did not find statistically significant differences between studies at lower and higher risk of bias (Supplement Table 5).

Table 1. Summary of Findings for Reduction of Unprocessed Red Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence

Table 1. Summary of Findings for Reduction of Unprocessed Red Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence
Overall cancer mortality and incidence of colorectal, pancreatic, breast, and prostate cancer had low-certainty evidence because of observational study design. The certainty of evidence was very low for prostate cancer mortality and overall cancer incidence because of observational design and imprecision and for esophageal and gastric cancer incidence because of observational design and risk of bias.

Dose–Response Meta-analysis of a Reduction in Processed Meat Intake of 3 Servings per Week and Cancer Mortality and Incidence

An intake reduction of 3 servings of processed meat per week was associated with very small reductions in overall cancer mortality and prostate cancer mortality but not with gastric or colorectal cancer mortality. The same intake reduction was also associated with very small decreases in incidence of esophageal and colorectal cancer but not with overall cancer incidence or incidence of oral, gastric, small intestinal, hepatic, pancreatic, endometrial, or prostate cancer. Only lowest-versus-highest meta-analyses were available for pancreatic cancer mortality and ovarian cancer incidence, and no statistically significant associations were found (Table 2). We observed a statistically significant interaction with risk of bias for overall cancer mortality; therefore, we present results only for studies at low risk of bias (Supplement Table 6). We found a nonlinear association between processed meat intake and breast cancer incidence (P = 0.015), and an intake reduction from 3 to 0 servings per week was associated with reduced risk for breast cancer incidence with low certainty. The RR estimates in the Figure are for processed meat consumption: Risk increased only marginally with intake greater than 3 servings per week.
Figure.

Nonlinear association between processed meat intake and breast cancer incidence.

The solid black line represents the point estimate, the shaded region represents the 95% CIs, and the tick marks represent the positions of the study-specific estimates.

Table 2. Summary of Findings for Reduction of Processed Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence

Table 2. Summary of Findings for Reduction of Processed Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence
The certainty of evidence was downgraded because of observational study design for overall cancer mortality; gastric and prostate cancer mortality; and incidence of small intestinal, colorectal, pancreatic, ovarian, breast, and prostate cancer. The certainty of evidence was very low for overall cancer incidence because of observational design and imprecision; it was also very low for colorectal and pancreatic cancer mortality and for incidence of oral, esophageal, gastric, hepatic, and endometrial cancer because of observational design and risk of bias (Table 2).

Dose–Response Meta-analysis of a Reduction in Mixed Unprocessed Red and Processed Meat Intake of 3 Servings per Week and Cancer Mortality and Incidence

An intake reduction of 3 servings of mixed unprocessed red and processed meat per week was associated with a very small reduction in overall cancer mortality but not with colorectal or prostate cancer mortality. Each intake reduction of 3 servings per week in mixed unprocessed red and processed meat was associated with a very small decrease in colorectal cancer incidence but not with overall cancer incidence or incidence of oral, esophageal, gastric, small intestinal, hepatic, pancreatic, endometrial, or prostate cancer. Only lowest-versus-highest meta-analyses were available for gastric, pancreatic, ovarian, and breast cancer mortality and ovarian cancer incidence, and no statistically significant associations were found (Supplement Table 7). We found no statistically significant differences between studies at lower and higher risk of bias (Supplement Table 8). We found a nonlinear association between intake of mixed unprocessed red and processed meat and breast cancer incidence (P = 0.018), and an intake reduction from 3 to 0 servings per week was associated with reduced risk for breast cancer incidence (Appendix Figure 2).
Appendix Figure 2.

Nonlinear association between intake of mixed unprocessed red and processed meat and breast cancer incidence.

The solid black line represents the point estimate, the shaded region represents the 95% CIs, and the tick marks represent the positions of the study-specific estimates.

The certainty of evidence was downgraded because of observational study design for overall cancer mortality; pancreatic cancer mortality; and incidence of small intestinal, colorectal, hepatic, pancreatic, ovarian, breast, and prostate cancer. Overall cancer incidence had very-low-certainty evidence because of observational design and imprecision. Certainty of evidence was also very low for gastric, colorectal, ovarian, breast, and prostate cancer mortality; overall cancer incidence; and incidence of oral, esophageal, gastric, and endometrial cancer because of observational design and risk of bias (Supplement Table 7).

Lowest-Versus-Highest Meta-analysis of Red Meat Intake and Cancer Mortality and Incidence

We found that lowest-versus-highest meta-analyses of red meat intake and cancer mortality and incidence were similar to the dose–response meta-analysis (Supplement Tables 9 to 11).

Discussion

This systematic review of observational studies documented low-certainty evidence that an intake reduction of 3 servings per week may result in 7 fewer deaths from cancer overall per 1000 persons for unprocessed red meat (Table 1) and 8 fewer deaths per 1000 persons for processed meat (Table 2). We also found evidence of low or very low certainty for very small reductions in prostate cancer mortality and incidence of esophageal, colorectal, and breast cancer with reduced consumption of processed meat by 3 servings per week (Table 2). We found evidence of low or very low certainty for very small reductions in overall cancer mortality, colorectal cancer incidence, and breast cancer incidence with a reduction in consumption of mixed unprocessed red and processed meat (Supplement Table 7). We did not find statistically significant associations between either exposure and mortality from or incidence of other cancer types.
Our systematic review has many strengths. We rated the certainty of evidence for red and processed meat intake and cancer risk from the entire body of evidence using GRADE guidance, thus highlighting the remaining uncertainty regarding causal relationships between meat consumption and cancer. We focused on dose–response analyses, which provide the most compelling evidence to assess these associations, and supported our findings with lowest-versus-highest analyses that provided similar results. Our review included an extensive search for all cohort studies with more than 1000 participants. We focused on studies that clearly separated unprocessed red meat from processed meat, but we also analyzed studies that did not make the distinction; these mixed analyses showed intermediate exposure effects compared with our estimates specific to unprocessed red and processed meat. Pairs of independent reviewers assessed eligibility, risk of bias, and data collection, with third-party adjudication of any discrepancies. When studies at low and high risk of bias produced discrepant results, we focused on those at low risk of bias. Presentation of results included not only relative but also absolute effects, which enabled us to document the very small reductions in cancer mortality and incidence over a lifetime associated with realistic decreases in meat consumption of 3 servings per week. These estimates inform the general public, as well as researchers, policymakers, and guideline developers, about the effects they might expect if indeed a causal relationship exists between red and processed meat consumption and cancer.
The main limitation of this review was its basis in observational studies prone to confounding; even with appropriate adjusted analyses, causal inferences from such studies are necessarily limited. Additional limitations included high risk of bias in some studies due to limited assessment of dietary intake and lack of adjustment for known confounders. Limitations in dietary assessment included measurement error due to recall-based methods and failure to report the alternative diets of patients with low consumption of red meat. Lack of adequate adjustment for potential confounders was one of the main sources of potential bias among eligible studies (47). We dealt with this issue by considering the possibility that studies at low and high risk of bias yielded systematically different estimates of effect; when this was the case, we focused on those at low risk of bias. Studies most often did not report sufficient data to inform our a priori planned subgroup analyses (that is, analyses of red vs. white processed meat and method of red meat preparation). Many studies did not report complete information for the purpose of dose–response meta-analysis.
Our results were consistent with those of previous systematic reviews of the RRs of cancer incidence and mortality associated with processed meat intake, which we identified in MEDLINE searches to April 2019. A recent systematic review summarized results from a meta-analysis on meat consumption and risk for 15 types of cancer, including 24 meta-analyses for total red meat and 39 for processed meat published between 2005 and 2015 (48). The authors concluded that a convincing association existed between larger intake of red meat and cancer, especially for colorectal, lung, esophageal, and gastric cancer. Similarly, they concluded that increased consumption of processed meat was associated with colorectal, esophageal, gastric, and bladder cancer. Several recent systematic reviews have also reported an association between red meat and specific cancer risks (49–53). Some of the meta-analyses relied on extreme exposure categories (48–50) and pooled case–control studies together with cohort studies (48), and many did not consider absolute effects or certainty of evidence on an outcome-by-outcome basis (15, 16, 49–54). Evidence of an association between unprocessed meat consumption and risk for cancer, however, proved difficult to compare between our review and previous systematic reviews, even for relative effects. Most primary studies did not distinguish between unprocessed and processed red meat, and most previous systematic reviews focused on total red meat, which included both unprocessed and processed meat (18–21, 55, 56). Our review provides up-to-date evidence separately for unprocessed red meat and processed meat, including the absolute effect and certainty of evidence for each outcome.
Regarding the implications of the results of our own and prior reviews, decision makers might expect that if red meat itself has a sufficient concentration of carcinogenic compounds to be causally related to cancer, the relative increases in incidence and mortality would be similar across cancer types regardless of whether meat was unprocessed or processed. Therefore, as noted in prior reviews (57, 58), results suggest that carcinogens may be added during meat processing procedures, such as curing, smoking, salting, or adding chemical preservatives (13, 57, 59). This suggests the desirability of future research addressing preservatives and processing procedures of red meat. For example, such research could focus on the direct relationship between preservatives and health outcomes (60, 61). On the other hand, differential levels of confounding may instead explain the gradient in cancer incidence and mortality between unprocessed and processed meat: For instance, lower socioeconomic status might be more strongly associated with consumption of processed than unprocessed red meat (62, 63).
Given the widespread consumption of red and processed meat and the large burden of cancer worldwide, this systematic summary provides relevant and useful information about important health concerns. Our systematic review and meta-analysis of cohort studies supports the association between red and processed meat intake and increased risk for cancer. The magnitude of red meat's effect on cancer over a lifetime of exposure was, however, very small, and the overall certainty of evidence was low or very low. Persons making recommendations about consumption of red and processed meat should be mindful of the remaining uncertainty regarding causation and, if indeed causal mechanisms are at play, the very small absolute effects.

Appendix: Technical Appendix

This appendix presents additional details on dose–response meta-analysis. We use our analysis addressing the association between unprocessed red meat intake and fatal stroke as an example.
Our systematic review identified 3 cohort studies reporting the association between unprocessed red meat and fatal stroke. The first 2 studies presented results across categories of exposure. The third reported results from a regression in which intake of unprocessed red meat was treated as a continuous variable. The relative effect presented in the third study corresponds to an increase in intake of 120 g/d.
Data are presented in Supplement Table 12, along with definitions of variables.
The following code loads the data and the necessary packages for the analysis.
library(dosresmeta)
library(metafor)
library(rms)
attach(filename)
The following code generates the natural logarithm of effect estimates and the associated SEs, which are stored in variables called log_point and se_point, respectively.
filename$log_point<-log(Adj_point)
filename$se_point<-(log(filename$CI_upper)-log(filename$CI_lower))/(2*1.96)
The following code approximates covariances of relative effects from the first 2 studies using the method proposed by Greenland and Longnecker (31) and estimates a corrected trend using generalized least-squares regression.
twostageresults <- dosresmeta(formula = log_point ~ Quantity, id = Ref, type = RType,
cases = Events, n = PY, data = filename,
se = se_point, proc = “2stage”, method=“reml”)
summary(twostageresults)
The estimated trend (that is, the regression coefficient) for the first 2 studies can be extracted from the above dose–response meta-analysis. Note that regression coefficients extracted from the dose–response meta-analysis correspond to 1 unit of intake (in this case, 1 g/d) but can be converted to correspond with any quantity of intake and can subsequently be meta-analyzed with the third study that treats the exposure as a continuous variable.
Here, we calculate effects for 1 serving per day and assume that each serving is equal to 120 g.
The following code meta-analyzes the relative effect from the third study with the relative effects from the first 2 studies that were derived on the basis of the method of Greenland and Longnecker (31).
serving <- 120
point1 <- 1.17
upperci1<- 1.33
lowerci1<- 1.03
bi1<-log(point1)/serving
si1<-((log(upperci1)-log(lowerci1))/(2*1.96*serving))^2
contbi<-c(bi1)
contsi<-c(si1)
Si<-unlist(twostageresults$Si)
newbi<-c(twostageresults$bi, contbi)
newsi<- c(Si, contsi)
meta<- rma.uni(yi=newbi*serving, vi=(sqrt(newsi)*serving)^2)
summary(meta)
The results from this analysis can be converted from 1 serving per day to a reduction of 3 servings per day by calculating the inverse of the effect, dividing by 7, multiplying by 3, and then subsequently exponentiating. This process can also be replicated for the upper and lower bounds of the CIs. This yields relative effect estimates corresponding to a reduction of 3 servings per week.
exp(-meta$beta/7*3)
exp(-meta$ci.lb/7*3)
exp(-meta$ci.ub/7*3)
The following code tests for nonlinearity using restricted cubic splines with knots at 10%, 50%, and 90%.
knots <- quantile(filename$Quantity, c(0.10, 0.50, 0.90))
nonlinear <-dosresmeta(formula = log_point ~ rcs(Quantity, knots), id = Ref,
type = RType, cases = Events, n = PY,
data = filename, se = se_point)
summary(nonlinear)
waldtest(b=coef(nonlinear), Sigma=vcov(nonlinear), Terms = 2)

References

  1. Bray
    F
    ,  
    Ferlay
    J
    ,  
    Soerjomataram
    I
    ,  
    et al
    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    CA Cancer J Clin
    2018
    68
    394
    424
     PubMed
    CrossRef
     PubMed
  2. Binnie
    MA
    ,  
    Barlow
    K
    ,  
    Johnson
    V
    ,  
    et al
    Red meats: time for a paradigm shift in dietary advice.
    Meat Sci
    2014
    98
    445
    51
     PubMed
    CrossRef
     PubMed
  3. Pan
    A
    ,  
    Sun
    Q
    ,  
    Bernstein
    AM
    ,  
    et al
    Red meat consumption and mortality: results from 2 prospective cohort studies.
    Arch Intern Med
    2012
    172
    555
    63
     PubMed
    CrossRef
     PubMed
  4. Norat
    T
    ,  
    Bingham
    S
    ,  
    Ferrari
    P
    ,  
    et al
    Meat, fish, and colorectal cancer risk: the European Prospective Investigation Into Cancer and Nutrition.
    J Natl Cancer Inst
    2005
    97
    906
    16
     PubMed
    CrossRef
     PubMed
  5. Larsson
    SC
    ,  
    Bergkvist
    L
    ,  
    Wolk
    A
    .  
    Processed meat consumption, dietary nitrosamines and stomach cancer risk in a cohort of Swedish women.
    Int J Cancer
    2006
    119
    915
    9
     PubMed
    CrossRef
     PubMed
  6. González
    CA
    ,  
    Jakszyn
    P
    ,  
    Pera
    G
    ,  
    et al
    Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).
    J Natl Cancer Inst
    2006
    98
    345
    54
     PubMed
    CrossRef
     PubMed
  7. Cho
    E
    ,  
    Spiegelman
    D
    ,  
    Hunter
    DJ
    ,  
    et al
    Premenopausal fat intake and risk of breast cancer.
    J Natl Cancer Inst
    2003
    95
    1079
    85
     PubMed
    CrossRef
     PubMed
  8. Rodriguez
    C
    ,  
    McCullough
    ML
    ,  
    Mondul
    AM
    ,  
    et al
    Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Cancer Epidemiol Biomarkers Prev
    2006
    15
    211
    6
     PubMed
    CrossRef
     PubMed
  9. Cross
    AJ
    ,  
    Leitzmann
    MF
    ,  
    Subar
    AF
    ,  
    et al
    A prospective study of meat and fat intake in relation to small intestinal cancer.
    Cancer Res
    2008
    68
    9274
    9
     PubMed
    CrossRef
     PubMed
  10. Takachi
    R
    ,  
    Tsubono
    Y
    ,  
    Baba
    K
    ,  
    et al
    Japan Public Health Center-Based Prospective Study Group
    Red meat intake may increase the risk of colon cancer in Japanese, a population with relatively low red meat consumption.
    Asia Pac J Clin Nutr
    2011
    20
    603
    12
     PubMed
     PubMed
  11. Fedirko
    V
    ,  
    Trichopolou
    A
    ,  
    Bamia
    C
    ,  
    et al
    Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation Into Cancer and Nutrition (EPIC).
    Ann Oncol
    2013
    24
    2166
    73
     PubMed
    CrossRef
     PubMed
  12. Ollberding
    NJ
    ,  
    Wilkens
    LR
    ,  
    Henderson
    BE
    ,  
    et al
    Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort Study.
    Int J Cancer
    2012
    131
    E1125
    33
     PubMed
    CrossRef
     PubMed
  13. Bouvard
    V
    ,  
    Loomis
    D
    ,  
    Guyton
    KZ
    ,  
    et al
    International Agency for Research on Cancer Monograph Working Group
    Carcinogenicity of consumption of red and processed meat.
    Lancet Oncol
    2015
    16
    1599
    600
     PubMed
    CrossRef
     PubMed
  14. World Cancer Research Fund/American Institute for Cancer Research
    Diet, Nutrition, Physical Activity and Cancer: A Global Perspective.
    London
    World Cancer Research Fund/American Institute for Cancer Research
    2018
  15. Zhao
    Z
    ,  
    Yin
    Z
    ,  
    Pu
    Z
    ,  
    et al
    Association between consumption of red and processed meat and pancreatic cancer risk: a systematic review and meta-analysis.
    Clin Gastroenterol Hepatol
    2017
    15
    486
    93
     PubMed
    CrossRef
     PubMed
  16. Vieira
    AR
    ,  
    Abar
    L
    ,  
    Chan
    DSM
    ,  
    et al
    Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project.
    Ann Oncol
    2017
    28
    1788
    802
     PubMed
    CrossRef
     PubMed
  17. Wu
    J
    ,  
    Zeng
    R
    ,  
    Huang
    J
    ,  
    et al
    Dietary protein sources and incidence of breast cancer: a dose-response meta-analysis of prospective studies.
    Nutrients
    2016
    8
     PubMed
  18. Guo
    J
    ,  
    Wei
    W
    ,  
    Zhan
    L
    .  
    Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies.
    Breast Cancer Res Treat
    2015
    151
    191
    8
     PubMed
    CrossRef
     PubMed
  19. Zhu
    H
    ,  
    Yang
    X
    ,  
    Zhang
    C
    ,  
    et al
    Red and processed meat intake is associated with higher gastric cancer risk: a meta-analysis of epidemiological observational studies.
    PLoS One
    2013
    8
    e70955
     PubMed
    CrossRef
     PubMed
  20. Xu
    J
    ,  
    Yang
    XX
    ,  
    Wu
    YG
    ,  
    et al
    Meat consumption and risk of oral cavity and oropharynx cancer: a meta-analysis of observational studies.
    PLoS One
    2014
    9
    e95048
     PubMed
    CrossRef
     PubMed
  21. Zhu
    HC
    ,  
    Yang
    X
    ,  
    Xu
    LP
    ,  
    et al
    Meat consumption is associated with esophageal cancer risk in a meat- and cancer-histological-type dependent manner.
    Dig Dis Sci
    2014
    59
    664
    73
     PubMed
    CrossRef
     PubMed
  22. Luo
    J
    ,  
    Yang
    Y
    ,  
    Liu
    J
    ,  
    et al
    Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma.
    Aliment Pharmacol Ther
    2014
    39
    913
    22
     PubMed
    CrossRef
     PubMed
  23. Johnston
    BC
    ,  
    Alonso-Coello
    P
    ,  
    Bala
    MM
    ,  
    et al
    Methods for trustworthy nutritional recommendations NutriRECS (Nutritional Recommendations and accessible Evidence summaries Composed of Systematic reviews): a protocol.
    BMC Med Res Methodol
    2018
    18
    162
     PubMed
    CrossRef
     PubMed
  24. Zeraatkar
    D
    ,  
    Johnston
    BC
    ,  
    Bartoszko
    J
    ,  
    et al
    Effect of lower versus higher red meat intake on cardiometabolic and cancer outcomes. A systematic review of randomized trials.
    Ann Intern Med
    2019
    171
    721
    31
  25. Zeraatkar
    D
    ,  
    Han
    MA
    ,  
    Guyatt
    GH
    ,  
    et al
    Red and processed meat consumption and risk for all-cause mortality and cardiometabolic outcomes. A systematic review and meta-analysis of cohort studies.
    Ann Intern Med
    2019
    171
    703
    10
  26. Vernooij
    RWM
    ,  
    Zeraatkar
    D
    ,  
    Han
    MA
    ,  
    et al
    Patterns of red and processed meat consumption and risk for cardiometabolic and cancer outcomes. A systematic review and meta-analysis of cohort studies.
    Ann Intern Med
    2019
    171
    732
    41
  27. Valli
    C
    ,  
    Rabassa
    M
    ,  
    Johnston
    BC
    ,  
    et al
    Health-related values and preferences regarding meat consumption. A mixed-methods systematic review.
    Ann Intern Med
    2019
    171
    742
    55
  28. Johnston
    BC
    ,  
    Zeraatkar
    D
    ,  
    Han
    MA
    ,  
    et al
    Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the Nutritional Recommendations (NutriRECS) Consortium.
    Ann Intern Med
    2019
    171
    756
    64
  29. Guyatt
    GH
    ,  
    Oxman
    AD
    ,  
    Kunz
    R
    ,  
    et al
    GRADE Working Group
    What is “quality of evidence” and why is it important to clinicians?
    BMJ
    2008
    336
    995
    8
     PubMed
    CrossRef
     PubMed
  30. Evidence Partners. Methodological resources. Accessed at www.evidencepartners.com/resources/methodological-resources on 11 December 2018.
  31. Greenland
    S
    ,  
    Longnecker
    MP
    .  
    Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.
    Am J Epidemiol
    1992
    135
    1301
    9
     PubMed
    CrossRef
     PubMed
  32. Orsini
    N
    ,  
    Bellocco
    R
    ,  
    Greenland
    S
    .  
    Generalized least squares for trend estimation of summarized dose–response data.
    Stata J
    2006
    6
    40
    57
    CrossRef
  33. Micha
    R
    ,  
    Khatibzadeh
    S
    ,  
    Shi
    P
    .  
    Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE)
    Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide.
    BMJ Open
    2015
    5
    e008705
     PubMed
    CrossRef
     PubMed
  34. Abete
    I
    ,  
    Romaguera
    D
    ,  
    Vieira
    AR
    ,  
    et al
    Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies.
    Br J Nutr
    2014
    112
    762
    75
     PubMed
    CrossRef
     PubMed
  35. Chen
    GC
    ,  
    Lv
    DB
    ,  
    Pang
    Z
    ,  
    et al
    Red and processed meat consumption and risk of stroke: a meta-analysis of prospective cohort studies.
    Eur J Clin Nutr
    2013
    67
    91
    5
     PubMed
    CrossRef
     PubMed
  36. Kaluza
    J
    ,  
    Wolk
    A
    ,  
    Larsson
    SC
    .  
    Red meat consumption and risk of stroke: a meta-analysis of prospective studies.
    Stroke
    2012
    43
    2556
    60
     PubMed
    CrossRef
     PubMed
  37. Larsson
    SC
    ,  
    Orsini
    N
    .  
    Red meat and processed meat consumption and all-cause mortality: a meta-analysis.
    Am J Epidemiol
    2014
    179
    282
    9
     PubMed
    CrossRef
     PubMed
  38. Pan
    A
    ,  
    Sun
    Q
    ,  
    Bernstein
    AM
    ,  
    et al
    Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis.
    Am J Clin Nutr
    2011
    94
    1088
    96
     PubMed
    CrossRef
     PubMed
  39. Schwingshackl
    L
    ,  
    Schwedhelm
    C
    ,  
    Hoffmann
    G
    ,  
    et al
    Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies.
    Am J Clin Nutr
    2017
    105
    1462
    73
     PubMed
     PubMed
  40. U.S. Department of Health and Human Services; U.S. Department of Agriculture
    2015–2020 Dietary Guidelines for Americans. 8th ed.
    Washington, DC
    U.S. Department of Agriculture
    2015
  41. Church
    S
    .  
    Trends in portion sizes in the UK - a preliminary review of published information
    London
    Food Standards Agency
    2008
  42. IntHout
    J
    ,  
    Ioannidis
    JP
    ,  
    Borm
    GF
    .  
    The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.
    BMC Med Res Methodol
    2014
    14
    25
     PubMed
    CrossRef
     PubMed
  43. DerSimonian
    R
    ,  
    Laird
    N
    .  
    Meta-analysis in clinical trials.
    Control Clin Trials
    1986
    7
    177
    88
     PubMed
    CrossRef
     PubMed
  44. Guyatt
    G
    ,  
    Oxman
    AD
    ,  
    Akl
    EA
    ,  
    et al
    GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables.
    J Clin Epidemiol
    2011
    64
    383
    94
     PubMed
    CrossRef
     PubMed
  45. Ferlay
    J
    ,  
    Soerjomataram
    I
    ,  
    Dikshit
    R
    ,  
    et al
    Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
    Int J Cancer
    2015
    136
    E359
    86
     PubMed
    CrossRef
     PubMed
  46. Guyatt
    GH
    ,  
    Oxman
    AD
    ,  
    Vist
    G
    ,  
    et al
    GRADE guidelines: 4.
    Rating the quality of evidence—study limitations (risk of bias). J Clin Epidemiol
    2011
    64
    407
    15
     PubMed
  47. Groenwold
    RH
    ,  
    Klungel
    OH
    ,  
    Grobbee
    DE
    ,  
    et al
    Selection of confounding variables should not be based on observed associations with exposure.
    Eur J Epidemiol
    2011
    26
    589
    93
     PubMed
    CrossRef
     PubMed
  48. Lippi
    G
    ,  
    Mattiuzzi
    C
    ,  
    Cervellin
    G
    .  
    Meat consumption and cancer risk: a critical review of published meta-analyses.
    Crit Rev Oncol Hematol
    2016
    97
    1
    14
     PubMed
    CrossRef
     PubMed
  49. Farvid
    MS
    ,  
    Stern
    MC
    ,  
    Norat
    T
    ,  
    et al
    Consumption of red and processed meat and breast cancer incidence: a systematic review and meta-analysis of prospective studies.
    Int J Cancer
    2018
    143
    2787
    99
     PubMed
    CrossRef
     PubMed
  50. Anderson
    JJ
    ,  
    Darwis
    NDM
    ,  
    Mackay
    DF
    ,  
    et al
    Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis.
    Eur J Cancer
    2018
    90
    73
    82
     PubMed
    CrossRef
     PubMed
  51. Schwingshackl
    L
    ,  
    Schwedhelm
    C
    ,  
    Hoffmann
    G
    ,  
    et al
    Food groups and risk of colorectal cancer.
    Int J Cancer
    2018
    142
    1748
    58
     PubMed
    CrossRef
     PubMed
  52. Zhao
    Z
    ,  
    Feng
    Q
    ,  
    Yin
    Z
    ,  
    et al
    Red and processed meat consumption and colorectal cancer risk: a systematic review and meta-analysis.
    Oncotarget
    2017
    8
    83306
    14
     PubMed
     PubMed
  53. Zhao
    Z
    ,  
    Yin
    Z
    ,  
    Zhao
    Q
    .  
    Red and processed meat consumption and gastric cancer risk: a systematic review and meta-analysis.
    Oncotarget
    2017
    8
    30563
    75
     PubMed
     PubMed
  54. Bylsma
    LC
    ,  
    Alexander
    DD
    .  
    A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer.
    Nutr J
    2015
    14
    125
     PubMed
    CrossRef
     PubMed
  55. Song
    P
    ,  
    Lu
    M
    ,  
    Yin
    Q
    ,  
    et al
    Red meat consumption and stomach cancer risk: a meta-analysis.
    J Cancer Res Clin Oncol
    2014
    140
    979
    92
     PubMed
    CrossRef
     PubMed
  56. Pham
    NM
    ,  
    Mizoue
    T
    ,  
    Tanaka
    K
    ,  
    et al
    Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
    Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.
    Jpn J Clin Oncol
    2014
    44
    641
    50
     PubMed
    CrossRef
     PubMed
  57. Domingo
    JL
    ,  
    Nadal
    M
    .  
    Carcinogenicity of consumption of red meat and processed meat: a review of scientific news since the IARC decision.
    Food Chem Toxicol
    2017
    105
    256
    61
     PubMed
    CrossRef
     PubMed
  58. Micha
    R
    ,  
    Michas
    G
    ,  
    Lajous
    M
    ,  
    et al
    Processing of meats and cardiovascular risk: time to focus on preservatives.
    BMC Med
    2013
    11
    136
     PubMed
    CrossRef
     PubMed
  59. Boada
    LD
    ,  
    Henríquez-Hernández
    LA
    ,  
    Luzardo
    OP
    .  
    The impact of red and processed meat consumption on cancer and other health outcomes: epidemiological evidences.
    Food Chem Toxicol
    2016
    92
    236
    44
     PubMed
    CrossRef
     PubMed
  60. Griesenbeck
    JS
    ,  
    Steck
    MD
    ,  
    Huber
    JC
    Jr
    ,  
    et al
    Development of estimates of dietary nitrates, nitrites, and nitrosamines for use with the Short Willet Food Frequency Questionnaire.
    Nutr J
    2009
    8
    16
     PubMed
    CrossRef
     PubMed
  61. Micha
    R
    ,  
    Wallace
    SK
    ,  
    Mozaffarian
    D
    .  
    Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis.
    Circulation
    2010
    121
    2271
    83
     PubMed
    CrossRef
     PubMed
  62. Clonan
    A
    ,  
    Roberts
    KE
    ,  
    Holdsworth
    M
    .  
    Socioeconomic and demographic drivers of red and processed meat consumption: implications for health and environmental sustainability.
    Proc Nutr Soc
    2016
    75
    367
    73
     PubMed
    CrossRef
     PubMed
  63. Guenther
    PM
    ,  
    Jensen
    HH
    ,  
    Batres-Marquez
    SP
    ,  
    et al
    Sociodemographic, knowledge, and attitudinal factors related to meat consumption in the United States.
    J Am Diet Assoc
    2005
    105
    1266
    74
     PubMed
    CrossRef
     PubMed
  64. Crippa
    A
    ,  
    Orsini
    N
    .  
    Multivariate dose-response meta-analysis: the dosresmeta R package.
    J Stat Softw
    2016
    72. doi
    10
Appendix Figure 1.

Evidence search and selection.

Figure.

Nonlinear association between processed meat intake and breast cancer incidence.

The solid black line represents the point estimate, the shaded region represents the 95% CIs, and the tick marks represent the positions of the study-specific estimates.

Appendix Figure 2.

Nonlinear association between intake of mixed unprocessed red and processed meat and breast cancer incidence.

The solid black line represents the point estimate, the shaded region represents the 95% CIs, and the tick marks represent the positions of the study-specific estimates.

Table 1. Summary of Findings for Reduction of Unprocessed Red Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence

Table 1. Summary of Findings for Reduction of Unprocessed Red Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence

Table 2. Summary of Findings for Reduction of Processed Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence

Table 2. Summary of Findings for Reduction of Processed Meat Intake (3 Servings per Week) and Cancer Mortality and Incidence
PDF Supplemental Content
Supplement. Supplementary Material

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Han MA, Zeraatkar D, Guyatt GH, et al. Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence: A Systematic Review and Meta-analysis of Cohort Studies. Ann Intern Med. 2019;171:711–720. [Epub ahead of print 1 October 2019]. doi: https://doi.org/10.7326/M19-0699

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2019;171(10):711-720.

DOI: 10.7326/M19-0699

Published at www.annals.org on 1 October 2019

©
2019 American College of Physicians
9 Citations

See Also

Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Cohort Studies
Health-Related Values and Preferences Regarding Meat Consumption: A Mixed-Methods Systematic Review
Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes: A Systematic Review of Randomized Trials
Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes: A Systematic Review and Meta-analysis of Cohort Studies
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium
Meat Consumption and Health: Food for Thought
View MoreView Less

Related Articles

Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Cohort Studies
Annals of Internal Medicine; 171 (10): 703-710
Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes: A Systematic Review of Randomized Trials
Annals of Internal Medicine; 171 (10): 721-731
Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes: A Systematic Review and Meta-analysis of Cohort Studies
Annals of Internal Medicine; 171 (10): 732-741
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium
Annals of Internal Medicine; 171 (10): 756-764
View MoreView Less

Journal Club

The 6-item CAPRA-S score predicted cancer recurrence after radical prostatectomy
Annals of Internal Medicine; 159 (10): JC13
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days
Annals of Internal Medicine; 170 (12): JC67
Review: In adults, general health checks do not reduce all-cause, cardiovascular, or cancer mortality
Annals of Internal Medicine; 170 (10): JC52
In patients with cancer who were starting chemotherapy, apixaban reduced VTE and increased major bleeding at 180 d
Annals of Internal Medicine; 170 (6): JC29
View MoreView Less

Related Point of Care

Prostate Cancer
Annals of Internal Medicine; 163 (11): ITC1
Care of the Adult Cancer Survivor
Annals of Internal Medicine; 158 (11): ITC6-1
View MoreView Less

Related Topics

Hematology/Oncology

Hematology/Oncology.

PubMed Articles

The Characteristic of Secondary Lung Tumours in Medan.
Open Access Maced J Med Sci 2019;7(16):2623-2625.
KIAA1211 plays an oncogenic role in human non-small cell lung cancer.
J Cancer 2019;10(26):6747-6753.
View More

Results provided by: PubMed

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×